Beta-lactams and beta-lactamase-inhibitors in current-or potential-clinical practice: a comprehensive update
The use of successive generations of β-lactams has selected successive generations of β-
lactamases including CTX-M ESBLs, AmpC β-lactamases, and KPC carbapenamases in …
lactamases including CTX-M ESBLs, AmpC β-lactamases, and KPC carbapenamases in …
[引用][C] Beta-lactams and Beta-lactamase-inhibitors in current-or potential-clinical practice: A comprehensive update
M SHAHID, F SOBIA, A SINGH… - Critical reviews in …, 2009 - pascal-francis.inist.fr
Beta-lactams and Beta-lactamase-inhibitors in current- or potential- clinical practice: A
comprehensive update CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
comprehensive update CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Beta-lactams and Beta-lactamase-inhibitors in current-or potential-clinical practice: A comprehensive update
M Shahid, E Sobia, A Singh… - Critical Reviews …, 2009 - research.birmingham.ac.uk
The use of successive generations of beta-lactams has selected successive generations of
beta-lactamases including CTX-M ESBLs, AmpC beta-lactamases, and KPC …
beta-lactamases including CTX-M ESBLs, AmpC beta-lactamases, and KPC …
Beta-lactams and beta-lactamase-inhibitors in current-or potential-clinical practice: a comprehensive update.
M Shahid, F Sobia, A Singh, A Malik… - Critical Reviews in …, 2009 - europepmc.org
The use of successive generations of beta-lactams has selected successive generations of
beta-lactamases including CTX-M ESBLs, AmpC beta-lactamases, and KPC …
beta-lactamases including CTX-M ESBLs, AmpC beta-lactamases, and KPC …
Beta-lactams and beta-lactamase-inhibitors in current-or potential-clinical practice: a comprehensive update
M Shahid, F Sobia, A Singh, A Malik… - Critical reviews in …, 2009 - pubmed.ncbi.nlm.nih.gov
The use of successive generations of beta-lactams has selected successive generations of
beta-lactamases including CTX-M ESBLs, AmpC beta-lactamases, and KPC …
beta-lactamases including CTX-M ESBLs, AmpC beta-lactamases, and KPC …
[PDF][PDF] Beta-lactams and Beta-lactamase-inhibitors in current-or potential-clinical practice: A comprehensive update
M Shahid, F Sobia, A Singh, A Malik… - Critical Reviews in …, 2009 - scholar.archive.org
The use of successive generations of β-lactams has selected successive generations of β-
lactamases including CTX-M ESBLs, AmpC β-lactamases, and KPC carbapenamases in …
lactamases including CTX-M ESBLs, AmpC β-lactamases, and KPC carbapenamases in …